N-Methyl-1,4-dioxaspiro[4.5]decan-8-amine hydrochloride (1:1)
[CAS# 1703755-78-5]

Identification

• Classification: Chemical reagent >> Organic reagent >> Amine salt (ammonium salt)
• Name: N-Methyl-1,4-dioxaspiro[4.5]decan-8-amine hydrochloride (1:1)
• Molecular Formula: C₉H₁₇NO₂^.HCl
• Molecular Weight: 207.70
• CAS Registry Number: 1703755-78-5
• SMILES: CNC1CCC2(CC1)OCCO2.Cl

Safety Data

• Hazard Symbols: GHS07 Warning
• Hazard Statements: H315-H319-H335
• Precautionary Statements: P261-P305+351+338-P302+352

Discovory and Applicatios

N-Methyl-1,4-dioxaspiro[4.5]decan-8-amine hydrochloride (1:1) is a chemical compound that belongs to a class of spirocyclic amines, which are characterized by a spiro structure where two rings are connected at a single atom. This compound has attracted attention due to its unique chemical structure and potential applications in medicinal chemistry, particularly for its pharmacological effects on the central nervous system. Its discovery was part of efforts to develop novel compounds with selective activity for various receptors and enzyme systems.

The spirocyclic structure of N-Methyl-1,4-dioxaspiro[4.5]decan-8-amine hydrochloride (1:1) imparts significant rigidity and specificity to its molecular conformation, which can be beneficial in drug design. The molecule consists of a dioxane ring fused to a decane ring, with an amine group attached to the spiro center. This structure allows the compound to exhibit unique interactions with biological systems, especially those involved in neurotransmission.

One of the primary applications of N-Methyl-1,4-dioxaspiro[4.5]decan-8-amine hydrochloride (1:1) is in the development of drugs aimed at modulating neurotransmitter systems in the brain. Its molecular structure is thought to enable it to interact with specific receptors or enzymes involved in the regulation of mood, cognition, and motor function. Although research into its precise mechanism of action is still ongoing, the compound has been explored for its potential neuropsychopharmacological effects, particularly in the treatment of neurological disorders such as depression, anxiety, and cognitive dysfunctions.

In addition to its neuropharmacological potential, N-Methyl-1,4-dioxaspiro[4.5]decan-8-amine hydrochloride (1:1) has been investigated for its possible role in other therapeutic areas. Its unique chemical properties make it a candidate for further studies in drug discovery, especially as part of a broader effort to create selective, targeted treatments with fewer side effects. The spirocyclic nature of the compound may provide advantages in terms of receptor specificity, potentially leading to safer and more effective therapies for a range of conditions.

The synthesis and characterization of spirocyclic compounds like N-Methyl-1,4-dioxaspiro[4.5]decan-8-amine hydrochloride (1:1) also contribute to the broader field of medicinal chemistry, which seeks to optimize drug design based on structural and functional criteria. Researchers are exploring various modifications to the basic structure to improve its pharmacological properties, such as bioavailability, selectivity, and pharmacokinetic profiles.

In conclusion, N-Methyl-1,4-dioxaspiro[4.5]decan-8-amine hydrochloride (1:1) represents an intriguing chemical entity with potential applications in the treatment of neurological disorders and possibly other areas of medicine. Its spirocyclic structure offers unique advantages for drug development, and ongoing research will likely further elucidate its mechanisms of action and therapeutic potential.